Immunic, Inc. (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback